Blood Filtration and Purification Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Genetic/Molecular Diagnostics is the fastest growing sector, North America is the largest market

The Global Blood Filtration and Purification Market is forecast to grow from USD 3.89 Billion in 2025 to USD 5.95 Billion by 2031, at a CAGR of 7.34%. These extracorporeal procedures are crucial for removing metabolic waste, toxins, and pathogens when renal or hepatic functions are compromised. This growth is primarily driven by the increasing worldwide incidence of chronic kidney disease (CKD) and the urgent need for sepsis management in intensive care settings, alongside a rising geriatric population susceptible to organ failure. Despite this demand, significant barriers to adoption include the high cost of long-term treatment and a shortage of specialized medical personnel in emerging economies, a challenge highlighted by the estimated 788 million adults globally living with CKD in 2025, underscoring the gap between therapeutic necessity and financial accessibility.

Market Drivers

The primary catalyst for market expansion is the escalating global prevalence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD), which necessitates continuous renal replacement therapies due to factors like aging populations and increasing metabolic disorders such as diabetes. This demand creates a non-cyclical need for dialysis equipment, exemplified by 831,192 individuals in the United States receiving ESRD treatment by the end of 2023. Further driving the market are technological advancements in portable systems and the growing adoption of home-based dialysis, shifting service delivery towards greater patient autonomy, with over 15% of patients at a major provider utilizing home-based modalities in 2024, supported by industry restructuring like Baxter's USD 3.8 billion divestiture of its Kidney Care business.

Market Challenges

A formidable barrier to the Global Blood Filtration and Purification Market's growth is the prohibitive cost of long-term treatment combined with a scarcity of specialized medical personnel, particularly in emerging economies. This economic constraint limits adoption despite substantial clinical need, as high capital requirements for equipment and recurring consumable expenses often exceed healthcare budgets in developing nations, hindering market penetration. Additionally, the effective deployment of sophisticated purification technologies is bottlenecked by a critical shortage of trained practitioners, including nephrologists and specialized nurses, required for managing extracorporeal procedures. This human capital deficit hampers service scalability, as reflected by an approximately 73% adult nephrology fellowship fill rate in 2025, stifling the market's capacity to deliver care effectively.

Market Trends

The sector is being transformed by the integration of Artificial Intelligence (AI) and the Internet of Things (IoT), moving focus from reactive treatment to predictive patient management. This involves embedding algorithms into dialysis infrastructure for real-time biometric monitoring and forecasting complications to reduce hospital readmissions, as demonstrated by a company introducing an AI-driven model to predict fall risks in dialysis patients. Concurrently, the market is seeing a significant expansion in the use of specialized hemoperfusion and adsorption cartridges for sepsis management. These therapies are designed to remove inflammatory mediators and cytokines from critically ill patients, addressing a gap in conventional intensive care protocols, with one leading technology already deployed in nearly 300,000 human treatments globally.

Key Market Players

• Fresenius Medical Care AG & Co. KGaA
• Baxter International Inc.
• B. Braun Melsungen AG
• Nikkiso Co., Ltd.
• Terumo Corporation
• Asahi Kasei Medical Co., Ltd.
• Kawasumi Laboratories, Inc.
• Medtronic plc
• Toray Medical Co., Ltd.
• Jafron Biomedical Co., Ltd.

Report Scope

In this report, the Global Blood Filtration and Purification Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Filtration and Purification Market, by Product:

• Filtration Kits and Reagents
• Membranes
• Filters and Consumables
• Sample Preparation Systems
• Specialty Assays
• Columns

Blood Filtration and Purification Market, by Application:

• Infectious Disease Diagnostics
• Toxicology and Immunodiagnostics
• Cancer Diagnostics
• Genetic/Molecular Diagnostics
• Others

Blood Filtration and Purification Market, by End User:

• Clinical Diagnostic Labs
• Hospitals
• Research and Academic Institutes
• Others

Blood Filtration and Purification Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Filtration and Purification Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.